Show
Sort by
-
- Journal Article
- A1
- open access
Immune complex glomerulonephritis in a patient with myelodysplastic syndrome with ring sideroblasts treated with luspatercept
-
- Journal Article
- A1
- open access
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL : the HOVON-100 trial
-
- Journal Article
- A1
- open access
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry
-
Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
-
GATA2 deficiency and haematopoietic stem cell transplantation : challenges for the clinical practitioner
-
Interruption or discontinuation of tyrosine kinase inhibitor treatment in chronic myeloid leukaemia : a retrospective cohort study (SPARKLE) in Belgium
-
Nurse led follow-up for CML patients on oral cancer treatment
-
The Medalist trial : results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to treat anemia in patients with very low-, low-, or intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (RS) who require red blood cell (RBC) transfusions
-
A crépinette sign